Blood Glucose System Manufacturer Cited For Quality System Violations
This article was originally published in The Gray Sheet
Executive Summary
Clinical Diagnostics failed to address FDA concerns about quality auditing and quality policy procedures for the Glucochek Pocketlab II glucose monitoring system in the company's Dec. 8 warning letter response, the agency states in a Jan. 5 follow-up letter.